We are live on
!
Find out more
Amphastar Pharmaceuticals
AMPH
AMPH
119 hedge funds and large institutions have $474M invested in Amphastar Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 42 increasing their positions, 49 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
1.32% more ownership
Funds ownership: 51% → 52.31% (+1.3%)
1% less capital invested
Capital invested by funds: $478M → $474M (-$4.04M)
11% less funds holding
Funds holding: 134 → 119 (-15)
14% less repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 49
61% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 23
91% less call options, than puts
Call options by funds: $32K | Put options by funds: $372K
Holders
119
Holders Change
-15
Holders Change %
-11.19%
% of All Funds
2.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
42
Reduced
49
Closed
23
Calls
$32K
Puts
$372K
Net Calls
-$340K
Net Calls Change
+$137K
Top Buyers
| 1 |
Invesco
Atlanta,
Georgia
|
+$8.17M |
| 2 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$5.45M |
| 3 |
Goldman Sachs
New York
|
+$4.22M |
| 4 |
BlackRock
New York
|
+$2.61M |
| 5 |
Renaissance Technologies
New York
|
+$1.96M |
Top Sellers
| 1 |
N
Nuveen
Charlotte,
North Carolina
|
-$3.17M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$2.62M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$2.29M |
| 4 |
MCM
Matarin Capital Management
New York
|
-$1.95M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1.41M |
